Cargando…
Elucidating the Role of Baseline Leukoaraiosis on Forecasting Clinical Outcome of Acute Ischemic Stroke Patients Undergoing Reperfusion Therapy
Stroke stands as a major cause of death and disability with increasing prevalence. The absence of clinical improvement after either intravenous thrombolysis (IVT) or mechanical thrombectomy (MT) represents a frequent concern in the setting of acute ischemic stroke (AIS). In an attempt to optimize ov...
Autores principales: | Karatzetzou, Stella, Tsiptsios, Dimitrios, Sousanidou, Anastasia, Christidi, Foteini, Psatha, Evlampia A., Chatzaki, Marilena, Kitmeridou, Sofia, Giannakou, Erasmia, Karavasilis, Efstratios, Kokkotis, Christos, Aggelousis, Nikolaos, Vadikolias, Konstantinos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9680372/ https://www.ncbi.nlm.nih.gov/pubmed/36412696 http://dx.doi.org/10.3390/neurolint14040074 |
Ejemplares similares
-
The Clinical Utility of Leukoaraiosis as a Prognostic Indicator in Ischemic Stroke Patients
por: Christidi, Foteini, et al.
Publicado: (2022) -
Diffusion Tensor Imaging as a Prognostic Tool for Recovery in Acute and Hyperacute Stroke
por: Christidi, Foteini, et al.
Publicado: (2022) -
Leukoaraiosis as a Promising Biomarker of Stroke Recurrence among Stroke Survivors: A Systematic Review
por: Dimaras, Theofanis, et al.
Publicado: (2023) -
Leukoaraiosis as a Predictor of Depression and Cognitive Impairment among Stroke Survivors: A Systematic Review
por: Tziaka, Eftychia, et al.
Publicado: (2023) -
Stroke and Emerging Blood Biomarkers: A Clinical Prospective
por: Gkantzios, Aimilios, et al.
Publicado: (2022)